Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancer

M (Mark) de Mol, Sabine Visser, BL Den Oudsten, P Lodder, N van Walree, H Belderbos, Joachim Aerts

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Scopus)
8 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)3563-3572
Number of pages10
JournalSupportive Care in Cancer
Volume27
Issue number9
DOIs
Publication statusPublished - 2019

Research programs

  • EMC OR-01

Cite this